skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis

Review

(2894) Views  (386) Full article downloads

Authors: V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al

Published Date September 2008 Volume 2008:4(5) Pages 1105 - 1110
DOI: http://dx.doi.org/10.2147/TCRM.S3782

V Nicosia1, Giorgio Colombo2, M Consentino1, S Di Matteo2, F Mika1, S De Sanctis1, S Ratti2, Marta Vinci2

1Saipem Medical Dept. San Donato Milanese, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milano, Italy

Objective: International travelers from non-endemic areas are at high risk of contracting malaria due to their lack of immunity. Prevention is therefore of outmost importance and is achieved through effective and safe chemoprophylaxis, which reduces the risk of fatal disease. Among the various antimalarial drugs available, the synergistic combination of atovaquone and proguanil (A/P) (Malarone®; Glaxo-SmithKline) has proven a valuable option in terms of effective protection against chloroquine and multi-drug resistant falciparum malaria, safety, tolerability, and ease of use, thus favoring compliance. The purpose of the present study was to assess acceptability and ease of use of A/P chemoprophylaxis in a population of employees of the oil industry bound to malarious areas. Particular attention was paid to treatment adherence.

Methods: A survey was conducted on a sample of 700 employees on A/P chemoprophylaxis. Demographic data and specific information on A/P treatment were collected by means of a 16-item questionnaire administered immediately before departure. All questionnaires returned were then entered into a database and statistically analyzed.

Results: Both habitual and first-time travelers showed good adherence to A/P chemoprophylactic regimen. In general, only few adverse side-effects were reported, none of which were serious. Travelers with previous experience of other antimalarials stated A/P prophylaxis had proven advantageous due to fewer adverse reactions, better condition of administration, and better sense of protection compared with other available treatments.

Keywords: atovaquone and proguanil, Malarone, malaria prophylaxis, prevention, compliance






 

Other articles by Professor Giorgio Colombo

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines


A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976
Moderate and severe plaque psoriasis: cost-of-illness study in Italy